Annual CFI
$35.81 M
-$213.17 M-85.62%
December 31, 2023
Summary
- As of February 7, 2025, CGEM annual cash flow from investing activities is $35.81 million, with the most recent change of -$213.17 million (-85.62%) on December 31, 2023.
- During the last 3 years, CGEM annual CFI has risen by +$41.23 million (+760.63%).
- CGEM annual CFI is now -85.62% below its all-time high of $248.97 million, reached on December 31, 2022.
Performance
CGEM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$19.88 M
+$204.99 M+110.74%
September 30, 2024
Summary
- As of February 7, 2025, CGEM quarterly cash flow from investing activities is $19.88 million, with the most recent change of +$204.99 million (+110.74%) on September 30, 2024.
- Over the past year, CGEM quarterly CFI has increased by +$204.99 million (+110.74%).
- CGEM quarterly CFI is now -93.39% below its all-time high of $300.85 million, reached on June 30, 2022.
Performance
CGEM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$100.81 M
+$62.84 M+38.40%
September 30, 2024
Summary
- As of February 7, 2025, CGEM TTM cash flow from investing activities is -$100.81 million, with the most recent change of +$62.84 million (+38.40%) on September 30, 2024.
- Over the past year, CGEM TTM CFI has increased by +$62.84 million (+38.40%).
- CGEM TTM CFI is now -134.28% below its all-time high of $294.11 million, reached on June 30, 2022.
Performance
CGEM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CGEM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.6% | +110.7% | +38.4% |
| 3 y3 years | +760.6% | +177.7% | +67.1% |
| 5 y5 years | +10000.0% | - | - |
CGEM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.6% | +110.7% | -93.4% | +110.7% | -134.3% | +69.8% |
| 5 y | 5-year | -85.6% | +110.7% | -93.4% | +110.7% | -134.3% | +69.8% |
| alltime | all time | -85.6% | +110.7% | -93.4% | +110.7% | -134.3% | +69.8% |
Cullinan Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $19.88 M(-110.7%) | -$100.81 M(-38.4%) |
| Jun 2024 | - | -$185.11 M(-1528.8%) | -$163.64 M(-587.4%) |
| Mar 2024 | - | $12.96 M(-74.8%) | $33.58 M(-6.2%) |
| Dec 2023 | $35.81 M(-85.6%) | $51.47 M(-219.8%) | $35.81 M(-180.9%) |
| Sep 2023 | - | -$42.96 M(-454.7%) | -$44.27 M(-25.3%) |
| Jun 2023 | - | $12.11 M(-20.2%) | -$59.29 M(-125.8%) |
| Mar 2023 | - | $15.18 M(-153.1%) | $229.45 M(-7.8%) |
| Dec 2022 | $248.97 M(-174.6%) | -$28.61 M(-50.7%) | $248.97 M(-4.9%) |
| Sep 2022 | - | -$57.98 M(-119.3%) | $261.72 M(-11.0%) |
| Jun 2022 | - | $300.85 M(+766.7%) | $294.11 M(-282.3%) |
| Mar 2022 | - | $34.71 M(-318.8%) | -$161.34 M(-51.7%) |
| Dec 2021 | -$333.77 M | -$15.86 M(-38.0%) | -$333.77 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$25.59 M(-83.4%) | -$306.47 M(+8.4%) |
| Jun 2021 | - | -$154.59 M(+12.2%) | -$282.82 M(+143.3%) |
| Mar 2021 | - | -$137.73 M(-1303.9%) | -$116.26 M(+2044.9%) |
| Dec 2020 | -$5.42 M(-84.7%) | $11.44 M(-689.4%) | -$5.42 M(-67.9%) |
| Sep 2020 | - | -$1.94 M(-116.2%) | -$16.86 M(+13.0%) |
| Jun 2020 | - | $11.97 M(-144.5%) | -$14.92 M(-44.5%) |
| Mar 2020 | - | -$26.89 M | -$26.89 M |
| Dec 2019 | -$35.40 M(>+9900.0%) | - | - |
| Dec 2018 | -$261.00 K(<-9900.0%) | - | - |
| Dec 2013 | $0.00(0.0%) | - | - |
| Dec 2012 | $0.00(0.0%) | - | - |
| Dec 2010 | $0.00(0.0%) | - | - |
| Dec 2007 | $0.00 | - | - |
FAQ
- What is Cullinan Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Cullinan Oncology?
- What is Cullinan Oncology annual CFI year-on-year change?
- What is Cullinan Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cullinan Oncology?
- What is Cullinan Oncology quarterly CFI year-on-year change?
- What is Cullinan Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cullinan Oncology?
- What is Cullinan Oncology TTM CFI year-on-year change?
What is Cullinan Oncology annual cash flow from investing activities?
The current annual CFI of CGEM is $35.81 M
What is the all time high annual CFI for Cullinan Oncology?
Cullinan Oncology all-time high annual cash flow from investing activities is $248.97 M
What is Cullinan Oncology annual CFI year-on-year change?
Over the past year, CGEM annual cash flow from investing activities has changed by -$213.17 M (-85.62%)
What is Cullinan Oncology quarterly cash flow from investing activities?
The current quarterly CFI of CGEM is $19.88 M
What is the all time high quarterly CFI for Cullinan Oncology?
Cullinan Oncology all-time high quarterly cash flow from investing activities is $300.85 M
What is Cullinan Oncology quarterly CFI year-on-year change?
Over the past year, CGEM quarterly cash flow from investing activities has changed by +$204.99 M (+110.74%)
What is Cullinan Oncology TTM cash flow from investing activities?
The current TTM CFI of CGEM is -$100.81 M
What is the all time high TTM CFI for Cullinan Oncology?
Cullinan Oncology all-time high TTM cash flow from investing activities is $294.11 M
What is Cullinan Oncology TTM CFI year-on-year change?
Over the past year, CGEM TTM cash flow from investing activities has changed by +$62.84 M (+38.40%)